articleNature MedicineJul 15, 2002Closed access

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo

SFSimone FuldaWWWolfgang WickMWMichael WellerKDKlaus‐Michael Debatin

University Hospital Ulm · University of Tübingen · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

741
total citations
FWCI
22.92
Percentile
100%
References
47
Citations per year

Authors

4

Topics & keywords

Topics
Keywords
  • In vivo
  • Glioma
  • Apoptosis
  • Cytotoxic T cell
  • Cancer research
  • Melanoma
  • Neuroblastoma
  • Ex vivo
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.